FLOT1 and non-small cell lung carcinoma: We previously reported that both the U2 and FERM domains of 4.1N are implicated in the 4.1N–flotillin-1 interaction for suppressing NSCLC cell proliferation and migration (Yang et al., 2016), uncovering the known binding within the U2 domain.